XML 24 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity - Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
$ / shares
shares
Number of Shares    
Outstanding at September 30, 2019 (in shares) | shares 1,686,902  
Granted (in shares) | shares 92,610  
Exercised (in shares) | shares (184,849)  
Canceled (in shares) | shares (16,146)  
Outstanding at March 31, 2020 (in shares) | shares 1,578,517 1,686,902
Weighted-Average Exercise Price    
Outstanding at September 30, 2019 (in dollars per share) | $ / shares $ 7.00  
Granted (in dollars per share) | $ / shares 9.49  
Exercised (in dollars per share) | $ / shares 3.49  
Canceled (in dollars per share) | $ / shares 10.40  
Outstanding at March 31, 2020 (in dollars per share) | $ / shares $ 7.52 $ 7.00
Weighted-Average Remaining Contractual Term (in Years)    
Outstanding 5 years 3 months 18 days 5 years 4 months 24 days
Outstanding, Aggregate Intrinsic Value | $ $ 2,557 $ 4,882
Vested and Expected to Vest at March 31, 2020    
Outstanding (in shares) | shares 1,578,517  
Weighted Average Exercise Price (in dollars per share) | $ / shares $ 7.52  
Weighted Average Remaining Contractual Term (in Years) 5 years 3 months 18 days  
Aggregate Intrinsic Value (in thousands) | $ $ 2,557  
Exercisable at March 31, 2020    
Exercisable (in shares) | shares 1,124,765  
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 6.76  
Exercisable, Weighted Average Remaining Contractual Term (in Years) 3 years 10 months 24 days  
Aggregate Intrinsic Value (in thousands) | $ $ 2,545